Forbidden Cures and Underground Medicine • I

Forbidden Cures and Underground Medicine • 83

This groundbreaking natutral cure halts the
most invasive breast cancer even when chemotherapy fails

1. Jiang, J., et al., BreastDefend™ prevents breast-to-lung cancer metastases in an
   orthotopic animal model of triple-negative human breast cancer. Oncol Rep.
   2012 Jul 26. doi: 10.3892/or.2012.1936. [Epub ahead of print]


2. Jiang, J, Wojnowski, R, Jedinak, A, Sliva, D. Suppression of Proliferation &
   Invasive Behavior of Human Metastatic Breast Cancer cells by Dietary Supple-
   ment BreastDefend. Integrative Cancer Therapies. (In Press) 2010.


3. Martínez-Montemayor MM, et al., Ganoderma lucidum (Reishi) inhibits cancer
   cell growth and expression of key molecules in inflammatory breast cancer. Nutr
   Cancer. 2011;63(7):1085-94. Epub 2011 Sep 2.


4. Hu, H., et al. Ganoderma lucidum extract induces cell cycle arrest and apoptosis
   in MCF-7 human breast cancer cell. Int J Cancer. 102(3):250-253, 2002.


5. Sliva, D., et al. Ganoderma lucidum suppresses motility of highly invasive breast
   and prostate cancer cells. Biochem Biophys Res Commun. 298(4):603-612, 2002.


6. Jiang, J., et al. Ganoderma lucidum suppresses growth of breast cancer cells through
   the inhibition of Akt/NF-B signaling. Nutrition & Cancer. 49(2):209-216, 2004.


7. Sliva, D., et al. Phellinus linteus suppresses growth, angiogenesis and invasive
   behaviour of breast cancer cells through the inhibition of AKT signalling. Br J
   Cancer. Apr 22;98(8):1348-56, 2008.


8. Eliza, W L, et al., Efficacy of Yun Zhi (Coriolus versicolor) on survival in cancer
   patients: systematic review and meta-analysis. Recent Pat Inflamm Allergy Drug
   Discov., 2012 Jan; 6(1):78-87


9. Kidd, P. M. The use of mushroom glucans and proteoglycans in cancer treat-
   ment. Alternative Medicine Review. 5(1):4-27, 2000.


10. Anticancer botanicals: Clinical studies show PSK enhances immune function. Works
    supportively with or without chemotherapy. Well Being Journal. 8(3):7, 1999.


11. Rahimi, M., et al. 3,3’-Diindolylmethane (DIM) inhibits the growth and inva-
    sion of drug-resistant human cancer cells expressing EGFR mutants. Cancer
    Lett. 295(1): 59-68, 2010.


12. Jin, Y., et al. 3,3’-Diindolylmethane (DIM) negatively regulates Cdc25A and
    induces a G2/M arrest by modulation of microRNA 21 in human breast cancer
    cells. Anticancer Drugs. 21(9):814-22, 2010.


13. Rugo H, Shtivelman E, Perez A, et al. Phase I trial and antitumor effects of
    BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat.
    2007 Sep;105(1):17-28. Epub 2006 Nov 17.


14. Hendler, Sheldon Saul. The Doctor’s Vitamin and Mineral Encyclopedia.
    Arrow Books, London, England. 1991:274-275

References